当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
E-cigarettes and dual nicotine replacement therapy for smoking cessation.
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2019-09-09 , DOI: 10.1016/s2213-2600(19)30308-x
Neal L Benowitz 1
Affiliation  

For many years, tobacco control researchers have speculated that nicotine delivery systems that allow the smoker to inhale nicotine similar to a cigarette, but without exposure to tobacco combustion products, would be much more acceptable and attractive to smokers than nicotine medications (nicotine replacement medication; NRT) and would substantially benefit public health. Smokers would be able to switch to a satisfying form of nicotine self-administration to manage their nicotine addiction without most of the harm from combusted tobacco. E-cigarettes were originally conceived and developed to meet such a need and can be considered a form of NRT. Epidemiological studies and a large clinical trial show that e-cigarettes are more effective than NRT alone for smoking cessation.

中文翻译:

电子烟和尼古丁双重替代疗法可用于戒烟。

多年以来,烟草控制研究人员推测,尼古丁输送系统可以使吸烟者像香烟一样吸入尼古丁,但不暴露于烟草燃烧产物,比尼古丁药物(尼古丁替代药物; NRT),将大大有益于公共卫生。吸烟者将能够转换成令人满意的尼古丁自我管理形式,以管理其尼古丁成瘾,而不会因燃烧烟叶带来大部分伤害。电子烟最初是为满足这种需求而设计和开发的,可以认为是NRT的一种形式。流行病学研究和一项大型临床试验表明,电子烟比单独使用NRT戒烟更有效。, 
更新日期:2019-12-20
down
wechat
bug